Latest News

Barclays is betting these 3 dividend stocks will beat the S&P 500 — if you’re looking for income, snag yields as high as 10.3%

0

Motley Fool

Why Novavax Plummeted by Over 6% Today

Novavax (NASDAQ: NVAX), one of the more up-and-down coronavirus stocks, headed south at the end of the week. There was no significant news about Novavax’s high-profile NVX-CoV2373 coronavirus vaccine, at least on the developmental or regulatory front. Rather, between Thursday night and Friday morning a pair of law firms issued reminders that their class action lawsuits against the company were moving forward. One of those suits, filed by San Francisco-based firm Hagens Berman, alleges that the “Defendants misrepresented Novavax’s progress toward successfully developing its COVID-19 vaccine.”

This is what both Suze Orman and Ramit Sethi say you should do if you’re worried about inflation

Previous article

GM locks in two deals that will bolster US rare earth magnet production

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News